亚临床甲状腺功能低下症会增加 normoglycemic 的人的胰岛素抵抗
Wanyu Yang1, Chenye Jin2, Haoyu Wang3
1Department of Geriatric Medicine, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in endocrinology
|July 24, 2023
概括
简单的亚临床甲状腺功能低下症 (SCH) 在没有糖尿病的个体中增加胰岛素抵抗. 甲状腺敏感度下降会增加糖尿病风险,这凸显了甲状腺功能在代谢健康中的重要性.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 甲状腺学 甲状腺学
背景情况:
- 亚临床甲状腺功能低下症 (SCH) 是一种常见的甲状腺疾病.
- 2型糖尿病 (T2DM) 是一种普遍的代谢障碍.
- 关于胰岛素耐药性的SCH和T2DM之间的相互作用需要进一步研究.
研究的目的:
- 调查SCH对胰岛素耐药性的影响.
- 检查T2DM和SCH对胰岛素抵抗的联合作用.
主要方法:
- 分析了622名新诊断T2DM患者和621名正常血糖控制者的队列.
- 参与者被分为正常甲状腺功能和SCH组.
- 血液样本分析了代谢和甲状腺的参数,包括HOMA-IR和TFQI.
主要成果:
- 与对照组相比,SCH在T2DM组 (14.95%) 中更为普遍.
- 在T2DM患者中,SCH没有显著改变HOMA-IR.
- 在正常血糖患者中,SCH与增加的BMI,腰比和HOMA-IR有关.
结论:
- 在正常葡萄糖代谢的个体中,SCH独立地对胰岛素耐药性有所贡献.
- 降低中央甲状腺敏感性与患糖尿病的风险增加有关.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Hypoglycemia and Glucagon
303
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
303
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Carbohydrate Metabolism
11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
Insulin: Dosing Regimen and Adverse Effects
212
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
212


